SEC 13F Intelligence

Nzs Capital, LLC / DC4

Nzs Capital, LLC’s Dexcom Inc Position

Does Nzs Capital, LLC own Dexcom Inc (DC4)? Not currently — the last reported position was 195.3K shares worth $27M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$27M
Q1 2024
Shares
195.3K
% of Portfolio
+1.12%
Quarters Held
7
position exited

Position History DC4

Reported value by quarter
Q3 ’22: $2MQ3 ’22Q4 ’22: $6MQ4 ’22Q1 ’23: $15MQ1 ’23Q2 ’23: $16MQ2 ’23Q3 ’23: $15MQ3 ’23Q4 ’23: $21MQ4 ’23Q1 ’24: $27MQ1 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2024195.3K$27M+1.12%
Q4 2023171.6K$21M+1.12%
Q3 2023160.5K$15M+0.81%
Q2 2023126.6K$16M+0.81%
Q1 2023124.8K$15M+0.77%
Q4 202250.8K$6M+0.49%
Q3 202226.4K$2M+0.20%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nzs Capital, LLC’s full portfolio or all institutional holders of DC4.